Kukje Pharma Co., Ltd. (KRX:002720)
South Korea · Delayed Price · Currency is KRW 4,535.00
+45.00 (1.00%)
Feb 19, 2026, 9:19 AM KST
Kukje Pharma Market Cap
Kukje Pharma has a market cap or net worth of 91.43 billion as of February 18, 2026. Its market cap has decreased by -12.98% in one year.
Market Cap
91.43B
Enterprise Value
103.79B
Revenue
173.80B
Ranking
n/a
PE Ratio
12.82
Stock Price
4,535.00
Market Cap Chart
Since July 3, 2006, Kukje Pharma's market cap has increased from 29.64B to 91.43B, an increase of 208.45%. That is a compound annual growth rate of 5.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 91.43B | 4.42% |
| Dec 30, 2025 | 87.56B | -15.02% |
| Dec 30, 2024 | 103.03B | -14.06% |
| Dec 28, 2023 | 119.89B | 12.98% |
| Dec 29, 2022 | 106.12B | -5.98% |
| Dec 30, 2021 | 112.86B | -36.19% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ilsung Is | 168.65B |
| Whan In Pharm | 164.27B |
| HANDOK | 145.50B |
| Kyongbo Pharmaceutical | 142.01B |
| Ildong Holdings | 131.55B |
| Jeil Pharma Holdings | 124.80B |
| CKD Bio | 115.48B |
| Enzychem Lifesciences | 88.50B |